loading
Aptevo Therapeutics Inc stock is traded at $1.98, with a volume of 122.62K. It is down -4.35% in the last 24 hours and down -36.74% over the past month. Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$2.07
Open:
$2.03
24h Volume:
122.62K
Relative Volume:
0.06
Market Cap:
$6.51M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0204
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
-1.00%
1M Performance:
-36.74%
6M Performance:
-97.15%
1Y Performance:
-99.30%
1-Day Range:
Value
$1.95
$2.0515
1-Week Range:
Value
$1.8701
$2.16
52-Week Range:
Value
$1.7197
$381.10

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
Name
Aptevo Therapeutics Inc
Name
Phone
206-838-0500
Name
Address
2401 4TH AVE., SEATTLE, WA
Name
Employee
37
Name
Twitter
@aptevo
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
APVO's Discussions on Twitter

Compare APVO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
APVO
Aptevo Therapeutics Inc
1.98 6.81M 12.99M -23.72M -23.28M -97.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-05-18 Initiated Ladenburg Thalmann Buy
Oct-05-17 Resumed Piper Jaffray Overweight

Aptevo Therapeutics Inc Stock (APVO) Latest News

pulisher
Aug 20, 2025

Published on: 2025-08-21 02:09:31 - classian.co.kr

Aug 20, 2025
pulisher
Aug 16, 2025

What’s the RSI of Aptevo Therapeutics Inc. stockTrade Performance Summary & High Return Stock Watch Alerts - mustnews.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

APVO stock plunges to 52-week low at $3.62 amid steep annual decline - MSN

Aug 16, 2025
pulisher
Aug 14, 2025

Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer - MarketScreener

Aug 14, 2025
pulisher
Aug 13, 2025

Aptevo highlights prostate cancer bispecific antibody candidate By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Aptevo's New Prostate Cancer Drug Shows Promise with Targeted Immune Response Technology - Stock Titan

Aug 13, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics APVO Q2 2025 Earnings Preview Downside Risk Over Lack of Revenue Growth - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Reports Q2 2025 Financials and Business Update, Raises $15.9M, and Advances Mipletamig and APVO455 Candidates - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update | APVO Stock News - GuruFocus

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics reports Q2 EPS ($8.40) vs. ($1,236.96) last year - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Reports 85% Remission in Q2 - The Motley Fool

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update - ACCESS Newswire

Aug 11, 2025
pulisher
Aug 11, 2025

Aptevo Reports Breakthrough: 85% Remission in AML Trial, Launches New Solid Tumor Program - Stock Titan

Aug 11, 2025
pulisher
Aug 10, 2025

Evaluating Aptevo Therapeutics Inc. with trendline analysisReal Time Trade Execution Alert Plan - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Aptevo Therapeutics Inc. likely to announce a buybackBest ROI Stocks This Month - sisain.net

Aug 10, 2025
pulisher
Aug 10, 2025

Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionWeekly Chart Watchlist with Trade Guidance - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Historical volatility pattern of Aptevo Therapeutics Inc. visualizedRisk-Managed Swing Setup and Signal Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Using data models to predict Aptevo Therapeutics Inc. stock movementSafe Entry Screening with Data Backed Analysis - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Aptevo Therapeutics Inc expected to post a loss of $83.20 a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Aptevo Therapeutics and 60 Degrees Pharmaceuticals to be Featured on Bloomberg TV's RedChip Small Stocks, Big Money Show - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Corinthian

Aug 08, 2025
pulisher
Aug 07, 2025

Aptevo Therapeutics (APVO) Expected to Announce Quarterly Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 04, 2025

Multi factor analysis applied to Aptevo Therapeutics Inc.Real Chart Based Opportunity Identification - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

How volatile is Aptevo Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Aptevo Therapeutics Inc. stockMaximize portfolio value with timely trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Aptevo Therapeutics Inc. a good long term investmentMaximize portfolio growth with expert advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Aptevo Therapeutics Inc. generate profit in a changing economyDiscover undervalued stocks ready to soar - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Aptevo Therapeutics Inc. compare to its industry peersDiscover high-impact stocks for your portfolio - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Aptevo Therapeutics Inc. stockHigh-octane financial growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Aptevo Therapeutics Inc. company’s balance sheetBuild a portfolio for long-term financial success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Aptevo Therapeutics Inc. stock attracting strong analyst attentionCapitalize on emerging growth stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Aptevo Therapeutics Inc. stock perform well during market downturnsTremendous wealth creation - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

When is Aptevo Therapeutics Inc. stock expected to show significant growthInvest smarter with actionable market insights - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What drives Aptevo Therapeutics Inc. stock priceUnlock daily market insights for better trades - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for Aptevo Therapeutics Inc.Build a portfolio for long-term financial success - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Should I hold or sell Aptevo Therapeutics Inc. stock in 2025Unlock your trading potential today - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Aptevo Therapeutics Inc. company’s key revenue driversBuild wealth faster with consistent growth stocks - Jammu Links News

Aug 02, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Aptevo Therapeutics Inc.Wealth Building Trend Scanner For Smart Trading - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Aptevo Therapeutics Inc. Shows Support at Fibonacci LevelFree Elite Traders Group - beatles.ru

Jul 30, 2025
pulisher
Jul 28, 2025

What is Aptevo Therapeutics Inc. company’s growth strategyInvest smarter with advanced market data - Jammu Links News

Jul 28, 2025

Aptevo Therapeutics Inc Stock (APVO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):